Recognition of emotional facial expressions in Alexithymia

Alexithymia is a personality trait which is associated with difficulties in identifying and verbalizing emotions. Previous studies have shown a significant association between alexithymia and a lack of ability to decode emotional facial expressions. Three groups of university students (N = 1645) were formed by splitting the sample based on Toronto Alexithymia Scale (TAS-20) scores. All participants performed an emotional expression recognition task, using the "Reading the Mind in the Eyes'" method. The experimenter presented images of the eye-region of the faces of actors and actresses. As expected, results showed that alexithymics performed worse on ability to infer others' emotional states expressed by the eyes. These results suggest that alexithymia is associated with impaired emotion recognition, that is most apparent when processing capacity is restricted, high-alexithymic individuals could develop less detailed perceptual representations of facial expression which might impair the process of drawing conclusions about its emotional significance

Integrative Oncogenomic Analysis of Microarray Data in Hematologic Malignancies

During the last decade, gene expression microarrays and array-based comparative genomic hybridization (array-CGH) have unraveled the complexity of human tumor genomes more precisely and comprehensively than ever before. More recently, the simultaneous assessment of global changes in messenger RNA (mRNA) expression and in DNA copy number through "integrative oncogenomic" analyses has allowed researchers the access to results uncovered through the analysis of one-dimensional data sets, thus accelerating cancer gene discovery. In this chapter, we discuss the major contributions of DNA microarrays to the study of hematological malignancies, focusing on the integrative oncogenomic approaches that correlate genomic and transcriptomic data. We also present the basic aspects of these methodologies and their present and future application in clinical oncology

Electron-hadron shower discrimination in a liquid argon time projection chamber

By exploiting structural differences between electromagnetic and hadronic showers in a multivariate analysis we present an efficient Electron-Hadron discrimination algorithm for liquid argon time projection chambers, validated using Geant4 simulated data

Mapping the Monoceros Ring in 3D with Pan-STARRS1

Using the Pan-STARRS1 survey, we derive limiting magnitude, spatial completeness, and density maps that we use to probe the three-dimensional structure and estimate the stellar mass of the so-called Monoceros Ring. The Monoceros Ring is an enormous and complex stellar sub-structure in the outer Milky Way disk. It is most visible across the large Galactic Anticenter region, $120^\circ \lt l\lt 240^\circ$, $-30^\circ \lt b\lt +40^\circ$. We estimate its stellar mass density profile along every line of sight in 2° × 2° pixels over the entire 30,000 deg2 Pan-STARRS1 survey using the previously developed match software. By parsing this distribution into a radially smooth component and the Monoceros Ring, we obtain its mass and distance from the Sun along each relevant line of sight. The Monoceros Ring is significantly closer to us in the south (6 kpc) than in the north (9 kpc). We also create 2D cross-sections parallel to the Galactic plane that show 135° of the Monoceros Ring in the south and 170° of the Monoceros Ring in the north. We show that the northern and southern structures are also roughly concentric circles, suggesting that they may be waves rippling from a common origin. Excluding the Galactic plane $\sim \pm 4^\circ$, we observe an excess mass of $4\times {10}^{6}{M}_{\odot }$ across $120^\circ \lt l\lt 240^\circ$. If we interpolate across the Galactic plane, we estimate that this region contains $8\times {10}^{6}{M}_{\odot }$. If we assume (somewhat boldly) that the Monoceros Ring is a set of two Galactocentric rings, its total mass is $6\times {10}^{7}{M}_{\odot }$. Finally, if we assume that it is a set of two circles centered at a point 4 kpc from the Galactic center in the anti-central direction, as our data suggests, we estimate its mass to be $4\times {10}^{7}{M}_{\odot }$

A novel determination of the local dark matter density

We present a novel study on the problem of constructing mass models for the Milky Way, concentrating on features regarding the dark matter halo component. We have considered a variegated sample of dynamical observables for the Galaxy, including several results which have appeared recently, and studied a 7- or 8-dimensional parameter space - defining the Galaxy model - by implementing a Bayesian approach to the parameter estimation based on a Markov Chain Monte Carlo method. The main result of this analysis is a novel determination of the local dark matter halo density which, assuming spherical symmetry and either an Einasto or an NFW density profile is found to be around 0.39 GeV cm$^{-3}$ with a 1-$\sigma$ error bar of about 7%; more precisely we find a $\rho_{DM}(R_0) = 0.385 \pm 0.027 \rm GeV cm^{-3}$ for the Einasto profile and $\rho_{DM}(R_0) = 0.389 \pm 0.025 \rm GeV cm^{-3}$ for the NFW. This is in contrast to the standard assumption that $\rho_{DM}(R_0)$ is about 0.3 GeV cm$^{-3}$ with an uncertainty of a factor of 2 to 3. A very precise determination of the local halo density is very important for interpreting direct dark matter detection experiments. Indeed the results we produced, together with the recent accurate determination of the local circular velocity, should be very useful to considerably narrow astrophysical uncertainties on direct dark matter detection.Comment: 31 pages,11 figures; minor changes in the text; two figures adde

Susceptibility and dilution effects of the kagome bi-layer geometrically frustrated network. A Ga-NMR study of SrCr_(9p)Ga_(12-9p)O_(19)

We present an extensive gallium NMR study of the geometrically frustrated kagome bi-layer compound SrCr_(9p)Ga_(12-9p)O_(19) (Cr^3+, S=3/2) over a broad Cr-concentration range (.72<p<.95). This allows us to probe locally the kagome bi-layer susceptibility and separate the intrinsic properties due to the geometric frustration from those related to the site dilution. Our major findings are: 1) The intrinsic kagome bi-layer susceptibility exhibits a maximum in temperature at 40-50 K and is robust to a dilution as high as ~20%. The maximum reveals the development of short range antiferromagnetic correlations; 2) At low-T, a highly dynamical state induces a strong wipe-out of the NMR intensity, regardless of dilution; 3) The low-T upturn observed in the macroscopic susceptibility is associated to paramagnetic defects which stem from the dilution of the kagome bi-layer. The low-T analysis of the NMR lineshape suggests that the defect can be associated with a staggered spin-response to the vacancies on the kagome bi-layer. This, altogether with the maximum in the kagome bi-layer susceptibility, is very similar to what is observed in most low-dimensional antiferromagnetic correlated systems; 4) The spin glass-like freezing observed at T_g=2-4 K is not driven by the dilution-induced defects.Comment: 19 pages, 19 figures, revised version resubmitted to PRB Minor modifications: Fig.11 and discussion in Sec.V on the NMR shif

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma

In Burkitt lymphoma/leukemia (BL), achievement of complete remission with first-line chemotherapy remains a challenging issue, as most patients who respond remain disease-free, whereas those refractory have few options of being rescued with salvage therapies. The mechanisms underlying BL chemoresistance and how it can be circumvented remain undetermined. We previously reported the frequent inactivation of the proapoptotic BIM gene in B-cell lymphomas. Here we show that BIM epigenetic silencing by concurrent promoter hypermethylation and deacetylation occurs frequently in primary BL samples and BL-derived cell lines. Remarkably, patients with BL with hypermethylated BIM presented lower complete remission rate (24% vs 79%; P = .002) and shorter overall survival (P = .007) than those with BIM-expressing lymphomas, indicating that BIM transcriptional repression may mediate tumor chemoresistance. Accordingly, by combining in vitro and in vivo studies of human BL-xenografts grown in immunodeficient RAG2(-/-)γc(-/-) mice and of murine B220(+)IgM(+) B-cell lymphomas generated in Eμ-MYC and Eμ-MYC-BIM(+/-) transgenes, we demonstrate that lymphoma chemoresistance is dictated by BIM gene dosage and is reversible on BIM reactivation by genetic manipulation or after treatment with histone-deacetylase inhibitors. We suggest that the combination of histone-deacetylase inhibitors and high-dose chemotherapy may overcome chemoresistance, achieve durable remission, and improve survival of patients with BL

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome

BACKGROUND: LMO2 is highly expressed at the most immature stages of lymphopoiesis. In T-lymphocytes, aberrant LMO2 expression beyond those stages leads to T-cell acute lymphoblastic leukemia, while in B cells LMO2 is also expressed in germinal center lymphocytes and diffuse large B-cell lymphomas, where it predicts better clinical outcome. The implication of LMO2 in B-cell acute lymphoblastic leukemia must still be explored. DESIGN AND METHODS: We measured LMO2 expression by real time RT-PCR in 247 acute lymphoblastic leukemia patient samples with cytogenetic data (144 of them also with survival and immunophenotypical data) and in normal hematopoietic and lymphoid cells. RESULTS: B-cell acute lymphoblastic leukemia cases expressed variable levels of LMO2 depending on immunophenotypical and cytogenetic features. Thus, the most immature subtype, pro-B cells, displayed three-fold higher LMO2 expression than pre-B cells, common-CD10+ or mature subtypes. Additionally, cases with TEL-AML1 or MLL rearrangements exhibited two-fold higher LMO2 expression compared to cases with BCR-ABL rearrangements or hyperdyploid karyotype. Clinically, high LMO2 expression correlated with better overall survival in adult patients (5-year survival rate 64.8% (42.5%-87.1%) vs. 25.8% (10.9%-40.7%), P= 0.001) and constituted a favorable independent prognostic factor in B-ALL with normal karyotype: 5-year survival rate 80.3% (66.4%-94.2%) vs. 63.0% (46.1%-79.9%) (P= 0.043). CONCLUSIONS: Our data indicate that LMO2 expression depends on the molecular features and the differentiation stage of B-cell acute lymphoblastic leukemia cells. Furthermore, assessment of LMO2 expression in adult patients with a normal karyotype, a group which lacks molecular prognostic factors, could be of clinical relevance

Experimental validation of an impact off-resonance energy harvester

Most piezoelectric energy harvesting research has focused on developing on-resonance harvesters that work at low frequencies, even though higher frequencies can generate more power. In addition, conventional resonant harvesters have low efficiency when the excitation frequency is away from resonance. Using mechanical impacts has the potential to improve the overall harvested energy since high frequencies are excited during impacts. Also, the presence of impacts reduces the influence of the base excitation frequency and the requirement to exactly match the resonance frequency. To take advantage of the higher frequency response, an impact energy harvester is designed and validated experimentally. The harvester consists of a cantilever beam with a piezoelectric patch attached to its base which impacts with a stiff object. The harvester is modelled using finite element analysis and a Hertzian contact law. The model is tested and validated in the laboratory using an in-house manufactured demonstrator. Good agreement with the experimental data is obtained, setting the basis for future optimisation of the harvester geometry and piezoelectric properties